New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms

• Hans C. Hasselbalch,
• Richard T. Silver

Affiliations

Hans C. Hasselbalch

1 Department of Hematology, Zealand University Hospital, Roskilde, Denmark

Richard T. Silver

2 Myeloproliferative Neoplasms Center, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York, USA